Press Room

 

New Research: Big Pharma’s Abuse of the US Patent System Costs Patients Billions Each Year

Pharma-constructed patent thickets on a single drug can cost consumers up to $7.6 billion in one year; Policy…

New Polling Shows Strong Majority of Americans Hold Drug Companies Most Responsible for High Drug Prices, Want Congress to Take Action

More than Two-Thirds of Americans Want Congress and the President to Take Action to Bring Down the Cost…

NEW REPORT: REBATES DO NOT RESULT IN HIGHER DRUG PRICES

Big Pharma, limited competition continue to drive prescription prices higher for patients Washington, D.C., March 1, 2022 –…

New Polling Shows Strong Majority of Americans Hold Big Drug Companies Responsible for High Drug Prices, Want Congress to Take Immediate Action

Washington, D.C., January 25, 2022 – Today, the Coalition for Affordable Prescription Drugs released new polling conducted by…

CAPD Statement on Oklahoma HB 2677

OKLAHOMA CITY, OK (February 11, 2021) – Today, The Coalition for Affordable Prescription Drugs (CAPD) released the following statement today in…

CAPD Statement on the Delay of the Effective Date of the Rebate Rule

Washington, D.C., February 2, 2021 – Today, the Coalition for Affordable Prescription Drugs (CAPD) released the following statement regarding the…

CAPD Statement on Senate Finance Committee Insulin Report

Washington, D.C., January 23, 2021 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the report…

CAPD Statement on PCMA Legal Action Against Trump Administration’s Rebate Rule

Washington, D.C., January 12, 2021 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the legal…